258 related articles for article (PubMed ID: 18837422)
1. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab treatment in severe adult atopic dermatitis.
Thaiwat S; Sangasapaviliya A
Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
[TBL] [Abstract][Full Text] [Related]
4. Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.
Kim DH; Park KY; Kim BJ; Kim MN; Mun SK
Clin Exp Dermatol; 2013 Jul; 38(5):496-500. PubMed ID: 23083013
[TBL] [Abstract][Full Text] [Related]
5. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
Amrol D
South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
[TBL] [Abstract][Full Text] [Related]
6. Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy.
Velling P; Skowasch D; Pabst S; Jansen E; Tuleta I; Grohé C
Eur J Med Res; 2011 Sep; 16(9):407-10. PubMed ID: 22024441
[TBL] [Abstract][Full Text] [Related]
7. [Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefit].
Schmitt J; Schäkel K
Hautarzt; 2007 Feb; 58(2):128, 130-2. PubMed ID: 17237929
[TBL] [Abstract][Full Text] [Related]
8. Effects of omalizumab in patients with food allergy.
Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
[TBL] [Abstract][Full Text] [Related]
9. [Dermatological implications of omalizumab, an anti-IgE antibody].
Di Lucca-Chrisment J
Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140
[TBL] [Abstract][Full Text] [Related]
10. Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial.
Iyengar SR; Hoyte EG; Loza A; Bonaccorso S; Chiang D; Umetsu DT; Nadeau KC
Int Arch Allergy Immunol; 2013; 162(1):89-93. PubMed ID: 23816920
[TBL] [Abstract][Full Text] [Related]
11. Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines.
Hotze M; Baurecht H; Rodríguez E; Chapman-Rothe N; Ollert M; Fölster-Holst R; Adamski J; Illig T; Ring J; Weidinger S
Allergy; 2014 Jan; 69(1):132-5. PubMed ID: 24111531
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results.
van den Berge M; Pauw RG; de Monchy JG; van Minnen CA; Postma DS; Kerstjens HA
Chest; 2011 Jan; 139(1):190-3. PubMed ID: 21208879
[TBL] [Abstract][Full Text] [Related]
13. Sequential combined therapy with omalizumab and rituximab: a new approach to severe atopic dermatitis.
Sánchez-Ramón S; Eguíluz-Gracia I; Rodríguez-Mazariego ME; Paravisini A; Zubeldia-Ortuño JM; Gil-Herrera J; Fernández-Cruz E; Suárez-Fernández R
J Investig Allergol Clin Immunol; 2013; 23(3):190-6. PubMed ID: 23967758
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab for the treatment of atopic dermatitis.
Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
[TBL] [Abstract][Full Text] [Related]
15. Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI.
Forman SB; Garrett AB
Cutis; 2007 Jul; 80(1):38-40. PubMed ID: 17725062
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab efficacy in a girl with atopic eczema.
Caruso C; Gaeta F; Valluzzi RL; Romano A
Allergy; 2010 Feb; 65(2):278-9. PubMed ID: 19796201
[No Abstract] [Full Text] [Related]
17. [Omalizumab in severe asthma--case report].
Gawlewicz-Mroczka A; Nizankowska-Mogilnicka E
Pol Arch Med Wewn; 2006 Aug; 116(2):766-70. PubMed ID: 17424922
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE--emerging opportunities for Omalizumab.
Babu KS; Polosa R; Morjaria JB
Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
[TBL] [Abstract][Full Text] [Related]
20. The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden.
Dewilde S; Turk F; Tambour M; Sandström T
Curr Med Res Opin; 2006 Sep; 22(9):1765-76. PubMed ID: 16968580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
